Abstract:Jian Sun, 1, &ast Zhaochun Tian, 2, &ast Jing Wu, 3 Jiafei Li, 3 Qixia Wang, 3 Shuhong Huang, 2, 3 Meng Wang 4 1 First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China; 2 Science and Technology Innovation Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China; 3 School of Clinical and Basic Medical Sciences, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China; 4 Department of General Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China &astThese authors contributed equally to this work Correspondence: Meng Wang, Department of general surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 16369, Jingshi Road, Jinan, Shandong, 250014, People's Republic of China, Email Shuhong Huang, School of Clinical and Basic Medical Sciences, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 6699, Qingdao Road, Jinan, Shandong, 250117, People's Republic of China, Email Pristimerin, a natural triterpenoid isolated from the plants of southern snake vine and Maidenwood in the family Weseraceae, is anti-inflammatory, insecticidal, antibacterial, and antiviral substance and has been used for its cardioprotective and antitumor effects and in osteoporosis treatment. These qualities explain Pristimerin's therapeutic effects on different types of tumors and other diseases. More and more studies have shown that pristimerin acts in a wide range of biological activities and has shown great potential in various fields of modern and Chinese medicine. While Pristimerin's wide range of pharmacological effects have been widely studied by others, our comprehensive review suggests that its mechanism of action may be through affecting fundamental cellular events, including blocking the cell cycle, inducing apoptosis and autophagy, and inhibiting cell migration and invasion, or through activating or inhibiting certain key molecules in several cell signaling pathways, including nuclear factor κB (NF-κB), phosphatidylinositol 3-kinase/protein kinase B/mammalian-targeted macromycin (PI3K/Akt/mTOR), mitogen-activated protein kinases (MAPKs), extracellular signal-regulated protein kinase 1/2 (ERK1/2), Jun amino-terminal kinase (JNK1/2/3), reactive oxygen species (ROS), wingless/integrin1 (Wnt)/β-catenin, and other signaling pathways. This paper reviews the research progress of Pristimerin's pharmacological mechanism of action in recent years to provide a theoretical basis for the molecular targeting therapy and further development and utilization of Pristimerin. It also provides insights into improved treatments and therapies for clinical patients and the need to explore pristimerin as a potential facet of treatment. Keywords: pristimerin, signaling pathway, pharmacological effects, review In recent years, natural compounds have attracted much attention in the treatment of human diseases due to their long history of use, diverse pharmacological effects and better safety than synthetic compounds.Pristimerin is a natural triterpenoid with orange-yellow needle-like crystals, a density of 1.16 g/cm3, a melting point of 214~217 °C, a boiling point of 607.7 °C, a refractive index of 1.582, a molecular weight of 464.64, and a molecular formula of C 30 H 40 O 4 . Pristimerin can be dissolved in methanol, ethanol, dimethylsulfoxide, and other organic solvents (Figure 1). 1 It is widely found in a variety of Weigeliaceae plants, such as southern snake vine (Celastrus orbiculatus Thunb.) and Maidenwood (Gymnosporia acuminata Hook. f.), and can be used in traditional Chinese medicine to treat a variety of diseases. There is considerable evidence that many natural products from traditional Chinese medicine, such as resveratrol, dioscin, berberine and curcumin, have antitumor effects.In contrast, Pristimerin has a broader range of biological effects, including anti-inflammatory, insecticidal, antibacterial, and antiviral effects and has been used for the treatment of osteoporosis and for cardioprotection, anti-tumor, and other biological effects.In addition, Pristimerin has significant potential for clinical application than other triterpenoids because it is a methyl ester of tretinoin, which not only acts similarly to tretinoin, but is also structurally stable, soluble, simple to obtain, has fewer toxic side effects, and inhibits tumor cell proliferation in a time- and dose-dependent manner. According to existi -Abstract Truncated-

Anticancer Potential and Molecular Targets of Pristimerin: A mini-review.

Anticancer Potential and Molecular Targets of Pristimerin in Human Malignancies

Pristimerin Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review

The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art

Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo

Pristimerin induces apoptosis and inhibits proliferation, migration in H1299 Lung Cancer Cells

Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells

Pristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signaling

Reactive oxygen species-dependent activation of Bax and poly(ADP-ribose) polymerase-1 is required for mitochondrial cell death induced by triterpenoid pristimerin in human cervical cancer cells

Scaffold Hopping of Pristimerin Provides Derivatives Containing a Privileged Quinoxaline Substructure as Potent Autophagy Inducers in Breast Cancer Cells

Pristimerin exerts antitumor activity against MDA-MB-231 triple-negative breast cancer cells by reversing of epithelial-mesenchymal transition via downregulation of integrin β3

Pristimerin Exacerbates Cellular Injury in Conditionally Reprogrammed Patient-Derived Lung Adenocarcinoma Cells by Aggravating Mitochondrial Impairment and Endoplasmic Reticulum Stress through EphB4/CDC42/N-WASP Signaling

Chemopreventive Agents from Nature: A Review of Apigenin, Rosmarinic Acid, and Thymoquinone

Recent progress on triterpenoid derivatives and their anticancer potential

Pristimerin Enhances the Effect of Cisplatin by Inhibiting the Mir‑23a/akt/gsk3β Signaling Pathway and Suppressing Autophagy in Lung Cancer Cells.

Triterpenoid pristimerin synergizes with taxol to induce cervical cancer cell death through reactive oxygen species-mediated mitochondrial dysfunction

Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss

Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis

Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27kip1 signaling pathway

Matrine: A Promising Natural Product With Various Pharmacological Activities

Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-B and ERK Signaling Pathways